News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Pharmaceutical industry news

Show

From To
New and experimental HIV treatments
ViiV Files Regulatory Applications for New Integrase Inhibitor Dolutegravir

ViiV Healthcare announced it has filed regulatory applications for the company’s investigational HIV integrase inhibitor dolutegravir.

Published
19 December 2012
From
AIDSMeds
New and experimental HIV treatments
ViiV Healthcare announces regulatory submissions for dolutegravir in the EU, US and Canada

ViiV Healthcare today announced the submission of regulatory applications in the European Union (EU), United States (US) and Canada for the investigational integrase inhibitor dolutegravir (S/GSK1349572) for the treatment of HIV infection in adults and adolescents.

Published
18 December 2012
From
ViiV press release
Pharmaceutical industry
Breaking Up With Gilead Sciences

Eventually, even perpetually bullish Wall Street analysts are going to realize the hepatitis C market is far smaller than current estimates suggest.

Published
17 December 2012
From
The Street
Pharmaceutical industry
US: AIDS physician groups tell pharma to lower prices

Two organizations that represent more than 5,000 physicians and other healthcare providers who are dedicated to HIV and AIDS care have written several drugmakers to various steps to expand access to their medicines, such as lowering prices, expanding co-pays, ensuring formulary coverage and participating in the Harbor Path program that provides patient assistance.

Published
12 December 2012
From
Pharmalot
Access to medicines and treatment
Thailand: Local HIV drugs offer lower prices

Public Health Minister Pradit Sinanarong said the local manufacturing of efavirenz and lopinavir/ritonavir will save on import costs and lower the cost to consumers.

Published
10 December 2012
From
Bangkok Post
Access to medicines and treatment
Brazil enters new era of co-production of anti-AIDS drugs

A new kind of public-private partnership will begin in 2013 in Brazil to produce an antiretroviral drug, through a technology transfer agreement that will be in effect until the patent expires in 2017.

Published
10 December 2012
From
Inter Press Service
HIV treatment in children
Childhood HIV Risks Becoming Neglected Disease As Fewer Children Born With HIV, Experts Warn

Because fewer children are born with the virus, drug companies no longer have an incentive to manufacture treatments - childhood HIV might become a neglected disease.

Published
06 December 2012
From
Kaiser Daily Global Health Policy Report
Access to medicines and treatment
Advocates to drugmakers: Join Patent Pool or else

A coalition of patient advocacy groups is planning to send a letter to drugmakers that have not joined the patent initiative to threaten they will pursue compulsory licenses for HIV and AIDS medications.

Published
06 December 2012
From
Pharmalot
Pharmaceutical industry
ITPC Open letter from activists in EECA about the Galien Prix Award goint to Merck for boceprevir

November 30, representatives of ECUO and ITPCru on behalf of the Community Advisory Board in Eastern Europe and Central Asia sent an open letter of protest to the Committee of the Prix Galien expressing their concern with regard to the Galien Award going to Merck for their Hep C drug boceprevir. 

Published
06 December 2012
From
EATG
Access to medicines and treatment
UNITAID statement on Johnson & Johnson’s darunavir announcement

Johnson & Johnson’s announcement does not go nearly far enough due to its limited geographical scope of just 64 countries.

Published
05 December 2012
From
UNITAID press release
← Prev1...34567...50Next →

Filter by country